Marios Politis

Publications


Journals

  • Garvey L; Pavese N; Politis M; Ramlackhansingh A; Taylor-Robinson S; Brooks D; Winston A. (1 Apr 2012). Microglial cell activation is visualised with [11C]-PK11195 Positron Emission Tomography (PET) in neuro-asymptomatic HIV infected subjects on effective antiretroviral therapy. HIV MEDICINE. 13:4-5. Author weblink.
  • Politis M; Wu K; Loane C; Quinn NP; Brooks DJ; Oertel WH; Björklund A; Lindvall O; et alPiccini P. (4 Apr 2012). Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Sci Transl Med. 4:128ra41. DOI.
  • Politis M; Piccini P. (2 Feb 2012). Positron emission tomography imaging in neurological disorders. J Neurol. DOI.
  • Politis M; Lindvall O. (2012). Clinical application of stem cell therapy in Parkinson's disease. BMC Med. 10:1. DOI.
  • Politis M; Loane C. (1 Jan 2011). Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability. THESCIENTIFICWORLDJOURNAL. 11:1726-1734. Author weblink DOI.
  • Loane C; Politis M. (15 Aug 2011). Positron emission tomography neuroimaging in Parkinson's disease. Am J Transl Res. 3:323-341.
  • Politis M; Loane C; Wu K; Brooks DJ; Piccini P. (Sep 2011). Serotonergic mediated body mass index changes in Parkinson's disease. Neurobiol Dis. 43:609-615. DOI.
  • Loane C; Su P; Politis M. EUROPEAN NEUROLOGICAL JOURNAL (ed). (2011). Different Dyskinesias in Parkinson’s Disease and Their Relationship to Levodopa. EUROPEAN NEUROLOGICAL JOURNAL. 1:20-26.
  • Su P; Loane C; Politis M. (2011). The use of stem cells in the treatment of Parkinson’s disease. INSIENCES J. 3:136-156.
  • Politis M; Loane C; Wu K; Brooks DJ; Piccini P. (1 Sep 2011). Serotonergic mediated body mass index changes in Parkinson's disease. NEUROBIOLOGY OF DISEASE. 43:609-615. DOI.
  • Politis M; Oertel WH; Wu K; Quinn NP; Pogarell O; Brooks DJ; Bjorklund A; Lindvall O; et alPiccini P. (Sep 2011). Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Mov Disord. 26:1997-2003. DOI.
  • Politis M. (2011). Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease. BMC Med. 9:50. DOI.
  • O'Sullivan SS; Wu K; Politis M; Lawrence AD; Evans AH; Bose SK; Djamshidian A; Lees AJ; et alPiccini P. (1 Apr 2011). Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. BRAIN. 134:969-978. Author weblink DOI.
  • Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; et alPiccini P. (Feb 2011). Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Hum Brain Mapp. 32:258-270. DOI.
  • Politis M; Wu K; Loane C; Turkheimer FE; Molloy S; Brooks DJ; Piccini P. (23 Nov 2010). Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology. 75:1920-1927. DOI.
  • Wu K; Politis M; O'Sullivan S; Bose S; Lees A; Piccini P. (15 Sep 2010). Impulse Control Disorders Subtypes in Parkinson's Disease: Clinical and PET Correlations. MOVEMENT DISORDERS. 25:S725-S726. Author weblink.
  • Wu K; Politis M; Warsi S; Loane C; O'Sullivan S; Lees A; Piccini P. (15 Sep 2010). Measuring Severity of Impulse Control Disorders in Parkinson's Disease Using Objective Validated Questionnaire. MOVEMENT DISORDERS. 25:S683-S684. Author weblink.
  • Kiferle L; Politis M; Muraro PA; Piccini P. (Feb 2011). Positron emission tomography imaging in multiple sclerosis-current status and future applications. Eur J Neurol. 18:226-231. DOI.
  • Politis M; Wu K; Loane C; Quinn NP; Brooks DJ; Rehncrona S; Bjorklund A; Lindvall O; et alPiccini P. (30 Jun 2010). Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med. 2:38ra46. DOI.
  • Politis M; Wu K; Loane C; Kiferle L; Molloy S; Brooks DJ; Piccini P. (Oct 2010). Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol Dis. 40:216-221. DOI.
  • Politis M; Wu K; Molloy S; G Bain P; Chaudhuri KR; Piccini P. (15 Aug 2010). Parkinson's disease symptoms: the patient's perspective. Mov Disord. 25:1646-1651. DOI.
  • Politis M; Piccini P. (2010). Brain imaging after neural transplantation. Prog Brain Res. 184:193-203. DOI.
  • Wu K; Politis M; Piccini P. (Nov 2009). Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J. 85:590-596. DOI.
  • Pavese N; Politis M; Tai YF; Barker RA; Tabrizi SJ; Mason SL; Brooks DJ; Piccini P. (Feb 2010). Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers. Neurobiol Dis. 37:356-361. DOI.
  • Politis M; Pavese N; Tai YF; Tabrizi SJ; Barker RA; Piccini P. (1 Nov 2008). Hypothalamic involvement in Huntingtons disease: an in vivo PET study. BRAIN. 131:2860-2869. Author weblink DOI.
  • Politis M; Piccini P; Pavese N; Koh SB; Brooks DJ. (Nov 2008). Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study. Exp Neurol. 214:112-116. DOI.
  • Politis M. Dyskinesias after neural transplantation in Parkinson's disease: What do we know and what is next?. BMC Med. 8:80.
  • Politis M; Wu K; Molloy S; P GB; Chaudhuri KR; Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord. 25:1646-1651.
  • Politis M; Wu K; Piccini P. Positron emission tomography in Parkinson’s disease. Minerva Psichiatr. 50:50-78.
  • Politis M; Pilinis C; Lekkas TD. Ultrafine particles (UFP) and health effects. Dangerous. Like no other PM?. Global Nest. 10:439-452.

Books

  • Piccini P; Politis M. Cell-Based Therapies: Imaging Outcomes. Imaging in PD.

Chapters in books

  • Loane C; Su P; Politis M. Imaging Dyskinesias in Parkinson’s Disease. InTech (ed). (2011).
  • Piccini P; Politis M. Cell-Based Therapies: Imaging Outcomes. In Imaging in Parkinson's Disease. Eidelberg (ed). Oxford University Press (2010).
  • Politis M; Piccini P. Brain imaging after neural transplantation. 184:193-203. Bjorklund A (ed). Elsevier (2010).

Conferences

  • Wu K; O'Keeffe D; Politis M; O'Keeffe G; Bose S; Brooks DJ; Barker R; Piccini P. IN VIVO EVIDENCE OF COMT VAL158MET FUNCTIONAL POLYMORPHISM MODULATES DIFFERENT LEVELS OF DOPAMINE TURNOVER IN PARKINSON'S DISEASE: AN 18F-DOPA PET STUDY. Annual Meeting of the Association-of-British-Neurologists, 2011. 83. B M J PUBLISHING GROUP (1 Mar 2012). DOI.
  • Politis M. Cortical Microglial Activation Is Associated with Disability in Secondary Progressive Multiple Sclerosis: An In Vivo Imaging Study. 62nd Annual Meeting of the American-Academy-of-Neurology, 10 Apr 2010 - 17 Apr 2010. A290-A290. Neurology (2010).
  • Giannetti P; Politis M; Su P; Turkheimer F; Wu K; Reynolds R; Nicholas R; Piccini P. Two different roles for microglia in vivo in T1 black holes in relapsing and progressive multiple sclerosis?. 21st Meeting of the European-Neurological-Society, 28 May 2011 - 31 May 2011. 258:221-221. SPRINGER HEIDELBERG (1 May 2011). Author weblink.
  • Wu K; O'Sullian S; Politis M; Bose S; Lees A; Piccini P. REWARDING VISUAL CUES INCREASE DOPAMINE NEUROTRANSMISSION IN PARKINSON'S PATIENTS WITH IMPULSE CONTROL DISORDERS: A PET STUDY. Annual Meeting of the Association-of-British-Neurologists, 11 May 2010 - 14 May 2010. 81:E29-E30. B M J PUBLISHING GROUP (1 Nov 2010). DOI.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook